
Gilead Sciences, McKesson, and Medtronic are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. “Medical stocks” are shares of companies involved in healthcare, such as pharmaceutical and biotechnology firms, medical-device makers, and healthcare providers. Investors may buy them to gain exposure to the healthcare industry, though their performance can depend on factors like regulation, clinical-trial results, and healthcare demand. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Gilead Sciences (GILD)
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.
NASDAQ:GILD traded down $0.20 during trading hours on Friday, hitting $166.33. 7,554,884 shares of the stock were exchanged, compared to its average volume of 6,363,988. The company has a current ratio of 1.38, a quick ratio of 1.22 and a debt-to-equity ratio of 1.84. The firm’s fifty day moving average price is $157.26 and its 200 day moving average price is $142.46. The company has a market cap of $206.30 billion, a P/E ratio of -52.64 and a beta of 0.35. Gilead Sciences has a 52-week low of $116.88 and a 52-week high of $176.58.
Read Our Latest Research Report on GILD
McKesson (MCK)
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
MCK stock traded up $7.15 during midday trading on Friday, reaching $1,069.31. The stock had a trading volume of 869,451 shares, compared to its average volume of 710,413. McKesson has a 52-week low of $723.68 and a 52-week high of $1,121.50. The company’s fifty day simple moving average is $974.65 and its 200 day simple moving average is $880.71. The company has a market cap of $123.46 billion, a price-to-earnings ratio of 27.50, a price-to-earnings-growth ratio of 1.81 and a beta of 0.27.
Read Our Latest Research Report on MCK
Medtronic (MDT)
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
Shares of MDT stock traded down $0.73 on Friday, hitting $99.88. 9,033,491 shares of the stock traded hands, compared to its average volume of 7,261,612. Medtronic has a twelve month low of $73.31 and a twelve month high of $106.33. The stock has a market capitalization of $127.75 billion, a PE ratio of 24.60, a PEG ratio of 2.34 and a beta of 0.56. The firm’s 50-day moving average price is $94.62 and its two-hundred day moving average price is $88.45. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.54 and a current ratio of 2.07.
Read Our Latest Research Report on MDT
See Also
- MarketBeat’s Top Five Stocks to Own in November 2026
- Growing Pains Versus Growth: Is BJ’s Wholesale Club a Buying Opportunity?
- Keysight Technologies: The Tollbooth on the Technology Superhighway
- Zscaler Got a Boost From Palo Alto, But Now It Has to Deliver.
- Bargain Hunting: Why Off-Price Retail Is Winning
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
